Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Rumina Hasan

Biographic Data

ID3761598
NAMERumina Hasan
GIVEN NAMESRumina
FAMILY NAMEHasan
SIGNATUREHASAN R
AFFILIATIONSAga Khan University
ORCID0000-0003-3738-117X
VERIFIEDYes
TOTAL WORKS10
TOTAL CITATIONS4
AUTHOR COUNT10
EDITOR COUNT0
FIRST PUBLICATION YEAR2007
LATEST PUBLICATION YEAR2024
H-INDEX1
  • Doctors taking bribes from pharmaceutical companies is common and not substantially reduced by an educational intervention

    Open Access•Mishal Khan, Muhammad Naveed Noor et al.•ARTICLE•BMJ Global Health•2024

    INTRODUCTION: Incentive-linked prescribing, which is when healthcare providers accept incentives from pharmaceutical companies for prescribing promoted medicines, is a form of bribery that harms patients and health systems globally. We developed a novel method using data collectors posing as pharmaceutical company sales representatives to evaluate private doctors' engagement in incentive-linked prescribing and the impact of a multifaceted educati…

  • Healthcare consumers’ perceptions of incentive-linked prescribing

    Open Access•Muhammad Naveed Noor, Haider Safdar Abbasi et al.•ARTICLE•PLOS Global Public Health•2024

    Incentive-linked prescribing (ILP) is considered a controversial practice universally. If incentivised, physicians may prioritise meeting pharmaceutical sales targets through prescriptions, rather than considering patients’ health and wellbeing. Despite the potential harms of ILP to patients and important stakeholders in the healthcare system, healthcare consumers (HCCs) which include patients and the general public often have far less awareness …

  • Socioecological factors linked with pharmaceutical incentive-driven prescribing in Pakistan

    Open Access•Muhammad Naveed Noor, Afifah Rahman-Shepherd et al.•ARTICLE•BMJ Global Health•2023

    Pharmaceutical marketing through financial incentivisation to general practitioners (GPs) is a poorly studied health system problem in Pakistan. Pharmaceutical incentivisation is seen to be distorting GPs prescribing behaviour that can compromise the health and well-being of patients. We draw on a conceptual framework outlined in the ecological system theory to identify multiple factors linked with pharmaceutical incentivisation to GPs in Pakista…

  • Incentivisation practices and their influence on physicians’ prescriptions

    Open Access•Mishal Khan, Afifah Rahman-Shepherd et al.•ARTICLE•PLOS Global Public Health•2023

    Focus on profit-generating enterprise in healthcare can create conflicts of interest that adversely impact prescribing and pricing of medicines. Although a global challenge, addressing the impacts on quality of care is particularly difficult in countries where the pharmaceutical industry and physician lobby is strong relative to regulatory institutions. Our study characterises the range of incentives exchanged between the pharmaceutical industry …

  • The healthcare field as a marketplace

    Muhammad Naveed Noor, Marco Liverani et al.•ARTICLE•Health Sociology Review•2023•References: 39

    Incentivisation of general practitioners (GPs) by pharmaceutical companies is thought to affect prescribing practices, often not in patients' interest. Using a Bourdieusian lens, we examine the socially structured conditions that underpin exchanges between pharmaceutical companies and GPs in Pakistan. The analysis of qualitative interviews with 28 GPs and 13 pharmaceutical sales representatives (PSRs) shows that GPs, through prescribing medicines…

  • Open Online Courses for Strengthening Laboratory-Based Detection of Antimicrobial Resistance in Pakistan

    Open Access•Noureen Saeed, Mohammad Zeeshan et al.•ARTICLE•Frontiers in Public Health•2022

    Introduction Quality-assured antimicrobial susceptibility testing (AST) depends upon the knowledge and skills of laboratory staff. In many low- and middle-income countries (LMICs), including Pakistan, such types of knowledge and skills are limited. Therefore, the objective of this study was to use openaccess online courses to improve the knowledge of laboratory staff involved in the detection and reporting of antimicrobial resistance (AMR). Metho…

  • How conflicts of interest hinder effective regulation of healthcare

    Open Access•Mishal Khan, Afifah Rahman-Shepherd et al.•ARTICLE•BMJ Global Health•2022

    BACKGROUND: There has been insufficient attention to a fundamental force shaping healthcare policies-conflicts of interest (COI). We investigated COI, which results in the professional judgement of a policymaker or healthcare provider being compromised by a secondary interest, in relation to antimicrobial use, thereby illuminating challenges to the regulation of medicines use more broadly. Our objectives were to characterise connections between t…

  • What are the barriers to implementing national antimicrobial resistance action plans? A novel mixed-methods policy analysis in Pakistan

    Open Access•Mishal Khan, Mishal S Khan et al.•ARTICLE•Health Policy and Planning•2020•Cited by: 1•References: 24

    Despite political commitment to address antimicrobial resistance (AMR), countries are facing challenges to implementing policies to reduce inappropriate use of antibiotics. Critical factors to the success of policy implementation in low- and middle-income countries (LMIC), such as capacity for enforcement, contestation by influential stakeholders and financial interests, have been insufficiently considered. Using Pakistan as a case study represen…

  • LMICs as reservoirs of AMR’

    Open Access•Mishal Khan, Mishal S Khan et al.•ARTICLE•Health Policy and Planning•2019•Cited by: 3•References: 24

    Antimicrobial resistance (AMR) has recently emerged as a salient global issue, and policy formulation to address AMR has become a contested space, with various actors sharing competing-and sometimes contradictory-explanations of the problem and the range of possible solutions. To facilitate national policy setting and implementation around AMR, more needs to be done to effectively engage policymakers in low- and middle-income countries (LMICs). H…

  • Hyperendemic pulmonary tuberculosis in peri-urban areas of Karachi, Pakistan

    Open Access•Saeed Akhtar, Franklin White et al.•ARTICLE•BMC Public Health•2007

    This study of previously undetected tuberculosis cases in an impoverished peri-urban setting reveals the poor operational performance of Pakistan's current approach to tuberculosis control; it also demonstrates a higher prevalence of pulmonary tuberculosis than current national estimates. Public health authorities may wish to augment health education efforts aimed at prompting health-seeking behaviour to facilitate more complete and earlier case …

  • LMICs as reservoirs of AMR’

    Open Access•Mishal Khan, Mishal S Khan et al.•ARTICLE•Health Policy and Planning•2019•Cited by: 3•References: 24

    Antimicrobial resistance (AMR) has recently emerged as a salient global issue, and policy formulation to address AMR has become a contested space, with various actors sharing competing-and sometimes contradictory-explanations of the problem and the range of possible solutions. To facilitate national policy setting and implementation around AMR, more needs to be done to effectively engage policymakers in low- and middle-income countries (LMICs). H…

  • What are the barriers to implementing national antimicrobial resistance action plans? A novel mixed-methods policy analysis in Pakistan

    Open Access•Mishal Khan, Mishal S Khan et al.•ARTICLE•Health Policy and Planning•2020•Cited by: 1•References: 24

    Despite political commitment to address antimicrobial resistance (AMR), countries are facing challenges to implementing policies to reduce inappropriate use of antibiotics. Critical factors to the success of policy implementation in low- and middle-income countries (LMIC), such as capacity for enforcement, contestation by influential stakeholders and financial interests, have been insufficiently considered. Using Pakistan as a case study represen…

  • Hyperendemic pulmonary tuberculosis in peri-urban areas of Karachi, Pakistan

    Open Access•Saeed Akhtar, Franklin White et al.•ARTICLE•BMC Public Health•2007

    This study of previously undetected tuberculosis cases in an impoverished peri-urban setting reveals the poor operational performance of Pakistan's current approach to tuberculosis control; it also demonstrates a higher prevalence of pulmonary tuberculosis than current national estimates. Public health authorities may wish to augment health education efforts aimed at prompting health-seeking behaviour to facilitate more complete and earlier case …

  • LMICs as reservoirs of AMR’

    Open Access•Mishal Khan, Mishal S Khan et al.•ARTICLE•Health Policy and Planning•2019•Cited by: 3•References: 24

    Antimicrobial resistance (AMR) has recently emerged as a salient global issue, and policy formulation to address AMR has become a contested space, with various actors sharing competing-and sometimes contradictory-explanations of the problem and the range of possible solutions. To facilitate national policy setting and implementation around AMR, more needs to be done to effectively engage policymakers in low- and middle-income countries (LMICs). H…

  • What are the barriers to implementing national antimicrobial resistance action plans? A novel mixed-methods policy analysis in Pakistan

    Open Access•Mishal Khan, Mishal S Khan et al.•ARTICLE•Health Policy and Planning•2020•Cited by: 1•References: 24

    Despite political commitment to address antimicrobial resistance (AMR), countries are facing challenges to implementing policies to reduce inappropriate use of antibiotics. Critical factors to the success of policy implementation in low- and middle-income countries (LMIC), such as capacity for enforcement, contestation by influential stakeholders and financial interests, have been insufficiently considered. Using Pakistan as a case study represen…

  • Open Online Courses for Strengthening Laboratory-Based Detection of Antimicrobial Resistance in Pakistan

    Open Access•Noureen Saeed, Mohammad Zeeshan et al.•ARTICLE•Frontiers in Public Health•2022

    Introduction Quality-assured antimicrobial susceptibility testing (AST) depends upon the knowledge and skills of laboratory staff. In many low- and middle-income countries (LMICs), including Pakistan, such types of knowledge and skills are limited. Therefore, the objective of this study was to use openaccess online courses to improve the knowledge of laboratory staff involved in the detection and reporting of antimicrobial resistance (AMR). Metho…

  • How conflicts of interest hinder effective regulation of healthcare

    Open Access•Mishal Khan, Afifah Rahman-Shepherd et al.•ARTICLE•BMJ Global Health•2022

    BACKGROUND: There has been insufficient attention to a fundamental force shaping healthcare policies-conflicts of interest (COI). We investigated COI, which results in the professional judgement of a policymaker or healthcare provider being compromised by a secondary interest, in relation to antimicrobial use, thereby illuminating challenges to the regulation of medicines use more broadly. Our objectives were to characterise connections between t…

  • Socioecological factors linked with pharmaceutical incentive-driven prescribing in Pakistan

    Open Access•Muhammad Naveed Noor, Afifah Rahman-Shepherd et al.•ARTICLE•BMJ Global Health•2023

    Pharmaceutical marketing through financial incentivisation to general practitioners (GPs) is a poorly studied health system problem in Pakistan. Pharmaceutical incentivisation is seen to be distorting GPs prescribing behaviour that can compromise the health and well-being of patients. We draw on a conceptual framework outlined in the ecological system theory to identify multiple factors linked with pharmaceutical incentivisation to GPs in Pakista…

  • Incentivisation practices and their influence on physicians’ prescriptions

    Open Access•Mishal Khan, Afifah Rahman-Shepherd et al.•ARTICLE•PLOS Global Public Health•2023

    Focus on profit-generating enterprise in healthcare can create conflicts of interest that adversely impact prescribing and pricing of medicines. Although a global challenge, addressing the impacts on quality of care is particularly difficult in countries where the pharmaceutical industry and physician lobby is strong relative to regulatory institutions. Our study characterises the range of incentives exchanged between the pharmaceutical industry …

  • The healthcare field as a marketplace

    Muhammad Naveed Noor, Marco Liverani et al.•ARTICLE•Health Sociology Review•2023•References: 39

    Incentivisation of general practitioners (GPs) by pharmaceutical companies is thought to affect prescribing practices, often not in patients' interest. Using a Bourdieusian lens, we examine the socially structured conditions that underpin exchanges between pharmaceutical companies and GPs in Pakistan. The analysis of qualitative interviews with 28 GPs and 13 pharmaceutical sales representatives (PSRs) shows that GPs, through prescribing medicines…

  • Doctors taking bribes from pharmaceutical companies is common and not substantially reduced by an educational intervention

    Open Access•Mishal Khan, Muhammad Naveed Noor et al.•ARTICLE•BMJ Global Health•2024

    INTRODUCTION: Incentive-linked prescribing, which is when healthcare providers accept incentives from pharmaceutical companies for prescribing promoted medicines, is a form of bribery that harms patients and health systems globally. We developed a novel method using data collectors posing as pharmaceutical company sales representatives to evaluate private doctors' engagement in incentive-linked prescribing and the impact of a multifaceted educati…

  • Healthcare consumers’ perceptions of incentive-linked prescribing

    Open Access•Muhammad Naveed Noor, Haider Safdar Abbasi et al.•ARTICLE•PLOS Global Public Health•2024

    Incentive-linked prescribing (ILP) is considered a controversial practice universally. If incentivised, physicians may prioritise meeting pharmaceutical sales targets through prescriptions, rather than considering patients’ health and wellbeing. Despite the potential harms of ILP to patients and important stakeholders in the healthcare system, healthcare consumers (HCCs) which include patients and the general public often have far less awareness …

Medicine (7 works) · Economics (6 works) · Health care (6 works) · Pharmaceutical Economics and Policy (6 works) · Pharmaceutical industry and healthcare (6 works) · Political science (6 works) · Business (5 works) · Public relations (5 works) · Antibiotic Use and Resistance (4 works) · Economic growth (4 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae